Anbc, Inc. (SYUP)

Market Cap	7.96K
Revenue (ttm)	50.95K
Net Income (ttm)	-382.25K
Shares Out	79.60M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	34,540
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0082
Beta	-5.43
RSI	41.30
Earnings Date	n/a

About Anbc, Inc.

Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-q...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Wei Dong
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SYUP

Financial Performance

In 2007, Anbc, Inc.'s revenue was $50,946, a decrease of -83.70% compared to the previous year's $312,494. Losses were -$382,246, 18.2% more than in 2006.